These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 2753022)

  • 1. Factors influencing serum levels of carbamazepine and carbamazepine-10,11-epoxide in children.
    Altafullah I; Talwar D; Loewenson R; Olson K; Lockman LA
    Epilepsy Res; 1989; 4(1):72-80. PubMed ID: 2753022
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of carbamazepine-10,11-epoxide on the serum level of valproic acid in epileptic patients on combined treatment with carbamazepine and valproic acid.
    Minkova GD; Getova DP
    Folia Med (Plovdiv); 2000; 42(3):16-9. PubMed ID: 11347330
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Developmental and therapeutic pharmacology of antiepileptic drugs.
    Miura H
    Epilepsia; 2000; 41 Suppl 9():2-6. PubMed ID: 11156504
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The influence of polytherapy on the relationships between serum carbamazepine and its metabolites in epileptic children.
    Liu H; Delgado MR
    Epilepsy Res; 1994 Mar; 17(3):257-69. PubMed ID: 8013448
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Factors influencing plasma concentrations of carbamazepine and carbamazepine-10,11-epoxide in epileptic children and adults.
    Lanchote VL; Bonato PS; Campos GM; Rodrigues I
    Ther Drug Monit; 1995 Feb; 17(1):47-52. PubMed ID: 7725376
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Routine therapeutic monitoring of the active metabolite of carbamazepine: Is it really necessary?
    Burianová I; Bořecká K
    Clin Biochem; 2015 Sep; 48(13-14):866-9. PubMed ID: 26018946
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationships between carbamazepine-diol, carbamazepine-epoxide, and carbamazepine total and free steady-state concentrations in epileptic patients: the influence of age, sex, and comedication.
    Svinarov DA; Pippenger CE
    Ther Drug Monit; 1996 Dec; 18(6):660-5. PubMed ID: 8946662
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lack of interaction of gabapentin with carbamazepine or valproate.
    Radulovic LL; Wilder BJ; Leppik IE; Bockbrader HN; Chang T; Posvar EL; Sedman AJ; Uthman BM; Erdman GR
    Epilepsia; 1994; 35(1):155-61. PubMed ID: 8112239
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Carbamazepine and carbamazepine-10,11-epoxide serum concentrations in epileptic children.
    Furlanut M; Montanari G; Bonin P; Casara GL
    J Pediatr; 1985 Mar; 106(3):491-5. PubMed ID: 3973787
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Carbamazepine metabolism in humans: effect of concurrent anticonvulsant therapy.
    Ramsay RE; McManus DQ; Guterman A; Briggle TV; Vazquez D; Perchalski R; Yost RA; Wong P
    Ther Drug Monit; 1990 May; 12(3):235-41. PubMed ID: 2112276
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Carbamazepine 10, 11 epoxide concentrations in epileptics on carbamazepine alone and in combination with other anticonvulsants.
    Brodie MJ; Forrest G; Rapeport WG
    Br J Clin Pharmacol; 1983 Dec; 16(6):747-9. PubMed ID: 6661364
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Valproic acid-induced carbamazepine-10,11-epoxide toxicity in children and adolescents.
    Rambeck B; Sälke-Treumann A; May T; Boenigk HE
    Eur Neurol; 1990; 30(2):79-83. PubMed ID: 2111243
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Kinetics of carbamazepine and its 10,11-epoxide metabolite in children.
    Rane A; Höjer B; Wilson JT
    Clin Pharmacol Ther; 1976 Mar; 19(3):276-83. PubMed ID: 1261166
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of CYP3A4/5 and ABCB1 genetic polymorphisms on carbamazepine metabolism and transport in Chinese patients with epilepsy treated with carbamazepine in monotherapy and bitherapy.
    Wang P; Yin T; Ma HY; Liu DQ; Sheng YH; Wang C; Zhou BT
    Epilepsy Res; 2015 Nov; 117():52-7. PubMed ID: 26421491
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Factors influencing simultaneous concentrations of total and free carbamazepine and carbamazepine-10, 11-epoxide in serum of children with epilepsy.
    Elyas AA; Patsalos PN; Agbato OA; Brett EM; Lascelles PT
    Ther Drug Monit; 1986; 8(3):288-92. PubMed ID: 3750372
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetic interactions between lamotrigine and other antiepileptic drugs in children with intractable epilepsy.
    Eriksson AS; Hoppu K; Nergårdh A; Boreus L
    Epilepsia; 1996 Aug; 37(8):769-73. PubMed ID: 8764817
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Population pharmacokinetic modeling of steady state clearance of carbamazepine and its epoxide metabolite from sparse routine clinical data.
    Jiao Z; Shi XJ; Zhao ZG; Zhong MK
    J Clin Pharm Ther; 2004 Jun; 29(3):247-56. PubMed ID: 15153086
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Carbamazepine and its epoxide: relation of plasma levels to toxicity and seizure control.
    Theodore WH; Narang PK; Holmes MD; Reeves P; Nice FJ
    Ann Neurol; 1989 Feb; 25(2):194-6. PubMed ID: 2919868
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vitamin D levels and bone turnover in epilepsy patients taking carbamazepine or oxcarbazepine.
    Mintzer S; Boppana P; Toguri J; DeSantis A
    Epilepsia; 2006 Mar; 47(3):510-5. PubMed ID: 16529614
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The metabolization of carbamazepine to CBZ-10,11-epoxide in children from the newborn age to adolescence.
    Korinthenberg R; Haug C; Hannak D
    Neuropediatrics; 1994 Aug; 25(4):214-6. PubMed ID: 7824094
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.